MAQUET AND SWISSTOM GIVE NOTICE OF DISTRIBUTION PARTNERSHIP FOR WESTERN EUROPE

Rastatt, Landquart (ots) - MAQUET and Swisstom are pleased to
announce their distribution partnership for the monitoring and
diagnostic product Swisstom BB2.

Acute Lung Injury is still a leading cause of death for intensive
care patients. Swisstom BB2 was especially developed to continuously
monitor the lung function of ICU patients undergoing mechanical
ventilation. It offers direct visualization of the lung aeration
complementing high performant MAQUET SERVO ventilators, which have a
long history in helping clinicians implementing protective
ventilation strategies. Now the positive effects of Neurally Adjusted
Ventilatory Assist (NAVA®) can be traced at the bedside with this
real-time Electrical Impedance Tomography (EIT). This monitoring of
ventilated patients is completely radiation-free. Therefore, Swisstom
BB2 can be used continuously for several days.

"Understanding what really happens in the lungs during mechanical
ventilation is still very challenging today", says Serge Exshaw, Vice
President MAQUET Holding and Head of Global Sales and Marketing.
MAQUET already developed tools including measured tidal volume per
kilogram of predicted body weight in the new SERVO-U. "However seeing
the lung aeration continuously and in real time represents a step
further for individual adaptation to patient condition", he
emphasizes. "We are really delighted about this partnership with
Swisstom." MAQUET is one of the leading companies in critical care
diagnostics and therapies. With its well-known brands like intensive
care ventilators SERVO-i® or the new SERVO-U, and the Neurally
Adjusted Ventilatory Assist (NAVA®), the company offers a wide range
of therapeutic options to treat all patient categories including the
sickest ones.

"Swisstom is proud to start a distribution partnership with MAQUET
in Western Europe. The broad product portfolio and the excellent
clinical knowhow of the MAQUET team combined with Swisstom's cutting
edge technology will provide brand new solutions for hospitals", says
Josef X. Brunner, Swisstom's CEO.

About Swisstom

Swisstom AG, located in Landquart, Switzerland, develops and
manufactures innovative medical devices. Swisstom creates its
competitive edge by passionate leadership in non-invasive tomography
with the goal to improve individual lives and therapies. For more
information please visit www.swisstom.com or contact Dr. J. X.
Brunner, CEO: jxb@swisstom.com.

About MAQUET

MAQUET, a trusted partner for hospitals and physicians for over
175 years, is the global leader in providing medical systems that
meet the needs of the most medically challenging patients, while
exceeding the expectations of the hospital teams that care for them.
MAQUET designs, develops and distributes innovative therapy solutions
and infrastructure capabilities for high-acuity areas within the
hospital including the operating room (OR), hybrid OR / cath lab and
intensive care unit (ICU) as well as intra and inter hospital patient
transport.

Headquartered in Rastatt, Germany, MAQUET is the largest
subsidiary of the publicly listed GETINGE Group AB of Sweden. MAQUET
generated about 1.54 billion Euros in 2013, representing more than
half of the Getinge Group's annual revenue of 2.9 billion Euros.
MAQUET has 6,550 employees in over 45 international sales and service
organizations, as well as a network of more than 300 sales partners.
For more information please visit www.maquet.com.

MAQUET - The Gold Standard
www.maquet.com
www.getingegroup.com
##

Media contact:

Product:
MAQUET Vertrieb und Service Deutschland GmbH
Markus Stirner-Schilling
VP Marketing Western Europe
Phone: +49 7222 932-914
email:markus.stirner-schilling@maquet.com

Corporate:
MAQUET Holding B.V. & Co. KG
Bettina Böttger-Kaul
Manager Corporate Communications
Phone: +49 7222 932-1284
email: bettina.boettger-kaul@maquet.com